Chairman, Independent Director of the Board
Michael Lim is the Chairman and an Independent Director.
He is also the Non-Executive Chairman of Nomura Singapore Limited and a Non-Executive Director of Nomura Holdings Limited. He was previously the Chairman of the Land Transport Authority of Singapore, the Singapore Accountancy Commission and National Healthcare Group Pte Ltd and a Non-Executive Director of Olam International Limited. Michael Lim also previously held various positions in PricewaterhouseCoopers Singapore from 1972 to 2003, with his last position being the Executive Chairman.
Michael Lim is a Fellow Chartered Accountant of Singapore and holds a Bachelor of Commerce and Administration from Victoria University of Wellington, New Zealand.
Deputy Chairman and Director of the Board
David Sin is the Deputy Chairman and Non-Executive Director. He was the Executive Chairman of our Company from 2012 to 2016.
David is the Chief Executive Officer of SIN Capital Group. Prior to that, he was at American International Group from 2007 to 2008 and Goldman Sachs International from 2003 to 2005.
David holds a Bachelor of Arts (Economics) (Honours) in Accounting and Finance from the University of Manchester and a Master in Business Administration from Harvard Business School.
Dr. Michael Tan
Co-founder and Group Chief Executive Officer
Dr. Michael Tan is our Group Chief Executive Officer and an Executive Director.
He is the co-founder of our Group and was previously with Parkway Shenton Singapore where he served as a medical director from 2003 to 2007 and Vice President (Business Development) from 2007 to 2008. He was also the Chief Executive Officer of Parkway East Hospital from 2008 to 2010.
Dr. Michael holds a Bachelor of Medicine and Bachelor of Surgery (MBBS), Graduate Diploma in Family Practice Dermatology and a Graduate Diploma in Occupational Medicine from the National University of Singapore. He also holds a Master of Business Administration from Imperial College of Science, Technology and Medicine. Dr. Michael is currently attending the Owner/President Management Program at Harvard Business School.
Dr. Daniel Chan
Co-Founder, Group Dy CEO, Executive Director and Regional MD - Singapore and Malaysia
Dr. Daniel Chan is our Group Deputy Chief Executive Officer, Managing Director, Singapore & Malaysia and an Executive Director.
He is the co-founder of our Group and was previously with Parkway Shenton Singapore from 2004 to 2008 where he served as a medical director and Vice President (Business Development). He was also the Chief Operating Officer of Parkway East Hospital from 2008 to 2010.
Dr. Daniel holds a Bachelor of Medicine and Bachelor of Surgery (MBBS) from Imperial College of Science, Technology and Medicine and a Graduate Diploma in Occupational Medicine from the National University of Singapore. Dr. Daniel also holds a Master of Business Administration from the University of Liverpool and a Family Physician qualification from the Singapore Medical Council. Dr. Daniel has been enrolled in the Advanced Management Program at Harvard Business School.
Edwin Basuki is a Non-Executive Director.
He has been a Managing Director at SIN Capital Group since 2015. He was previously a Senior Vice President at a subsidiary of DBS Group from 2013 to 2015, focusing on Direct Investments and Capital Markets. Prior to that, he was an Executive Director with the Investment Banking team at Goldman Sachs from 2010 to 2013, a Senior Vice President with the Investment Banking team at Macquarie Capital from 2005 to 2010 and an Associate Analyst with the Equity Research team at Macquarie Securities from 2002 to 2004.
Edwin holds a Bachelor of Engineering (Honours) in Chemical Engineering from University College London and a Master of Science in Management Science and Engineering from Stanford University.
Sherwin Loh is a Non-Executive Director.
He has been a Managing Director at SIN Capital Group since 2013 and was previously with Goldman Sachs (Hong Kong) from 2010 to 2013 and Goldman Sachs (London) from 2003 to 2006, his last held position being Executive Director in the Financing Group, Investment Banking Division.
He was also previously a Vice President in the Equity-Linked and Corporate Derivatives Origination and Equity Capital Markets teams of J.P. Morgan (Hong Kong and Singapore) from 2006 to 2010. Sherwin holds a Bachelor of Science in Actuarial Science (Honours) from the London School of Economics and Political Science.
Dr. Teh Kok Peng
Dr. Teh Kok Peng is an Independent Director.
He is also a Non-Executive Director of Oversea-Chinese Banking Corporation Limited and Sembcorp Industries. Dr. Teh was formerly the President of GIC Special Investments Private Limited from 1999 to 2011 and was with the Monetary Authority of Singapore from 1981 to 1999, with his last position being Deputy Managing Director. He was also formerly a Project Economist with the World Bank from 1975 to 1981.
Dr. Teh holds a Doctor of Philosophy from the University of Oxford and a Bachelor of Economics from La Trobe University.
Robert Yap is an Independent Director.
He is currently the Deputy Chairman and Executive Director of Y3 Technologies. Robert is currently also the Chairman of the Institute for Service Excellence Board of Advisors of the Singapore Management University and the Chairman of the Board of Advisors of the School of Information Systems of the Singapore Management University. Robert was formerly the President of DFS Venture and Group Executive Vice President of DFS Group from 2004 to 2014, Chief Executive Officer, East Asia, of PSA International from 2000 to 2004, a director at Philips Electronics Asia Pacific from 1999 to 2000 and a Divisional Director at FJ Benjamin from 1995 to 1999.
Robert holds a Bachelor of Engineering and Master of Engineering Science from the University of New South Wales.